Insurtech AI startups captured 95.2% of Q1 2026's $1.63 billion in venture funding, the highest concentration Gallagher Re has recorded, and the money kept landing in the same three functions through the first half: submission intake, underwriting triage and claims (Gallagher Re, May 2026).

Sixfold, Shepherd and Outmarket each closed rounds there. None went to a standalone pricing or reserving engine, and that absence is the datapoint.

Key Takeaways

  • 95.2% of $1.63 billion went to AI-labeled deals across 68 rounds averaging $25.79 million, against roughly 13 non-AI rounds splitting about $80 million, or $6.2 million apiece.
  • $270 billion of gross written premium already runs Sixfold's AI Underwriter within months of its June launch, the kind of ROI metric a rating engine cannot produce inside a funding cycle.
  • No rating or reserving engine raised at comparable scale in the half. The capital is buying workflow around the underwriting decision, not the decision itself.
  • 82% of insurtechs that raised in Q1 will not be ready to raise again for at least six months, 17 percentage points longer than the broader venture market.
  • Norm AI closed $120 million at a $1.2 billion valuation, crossing unicorn status in under three years on model governance rather than on any pricing capability.

Three Raises, Three Points in the Workflow

The arithmetic behind the concentration is worth doing. Gallagher Re counted 68 AI-labeled deals at an average round size of $25.79 million, while CB Insights put total Q1 deal count at 81. That leaves roughly 13 non-AI rounds splitting the remaining $80 million, about $6.2 million apiece, a four-to-one size gap computed from two independently sourced totals.

Sixfold closed a $30 million Series B on January 29, 2026, led by Brewer Lane Capital with strategic participation from Guidewire, taking total funding past $50 million (Fintech Global). Its AI Underwriter launched June 15 across six carriers representing $270 billion in gross written premium (The Insurer).

Shepherd followed with $42 million on March 24, led by Intact Private Capital, bringing its total to $67 million (PR Newswire). It insures physical infrastructure for AI and data-center builders, and has grown revenue more than sevenfold in 24 months across $400 billion of insured project value (Carrier Management). Outmarket AI raised $17 million on May 13, lifting its total to $21.7 million, automating broker-side intake across more than 250 brokerages.

Function Representative H1 2026 raise Amount Actuarial core function present?
Submission intake / broker workflow Outmarket AI (Series A, May 2026) $17M No
Underwriting decisioning Sixfold (Series B, January 2026) $30M Adjacent (uses carrier rating output, does not set it)
Underwriting + risk monitoring Shepherd (Series B, March 2026) $42M No
Claims triage / adjudication Reserv (Series C, Q1 2026) $125M No
AI-native carrier paper Corgi (Series B, Q1 2026) $160M No (writes on its own paper; pricing is internal, not vendor-sold)
Model governance Norm AI (Series C, July 2026) $120M No
Rating / pricing engine None disclosed at comparable scale — N/A
Reserving engine None disclosed at comparable scale — N/A

Widen the lens and the pattern repeats at the top of the table. Corgi's $160 million Series B funded an AI-native carrier writing liability and cyber paper, not a rating engine. Reserv's $125 million Series C funded claims triage at $100 million of annual recurring revenue. Counterpart's $50 million funded SME cyber underwriting workflow. Norm AI closed $120 million at a $1.2 billion valuation in July (InsurTech.ME).

The bottom rows carry the finding, and it needs stating precisely. Capital has gone to actuarial pricing software before; Akur8 sells rate-filing intelligence tooling and EXL holds a substantial AI patent position. Neither appears among the half's largest raises, and no comparable new entrant challenged them.

The Layer Investors Will Not Fund Is the One That Cannot Be Outsourced

The economics explain the split. Intake, triage and claims automation solve throughput. A carrier processing 370,000 submissions a year cares intensely about compressing a two-to-four-week underwriting cycle into minutes, because that compression captures business that lapses to a faster competitor. The ROI metric is observable inside a funding cycle, which is why Sixfold could point to $270 billion of in-production premium within months.

Pricing and reserving software sells a slower story. A rating engine's value is measured in loss ratio points and reserve adequacy, both of which need years of earned exposure to validate. The vendor also has to convince a chief actuary to rely on its output under sign-off requirements it cannot absorb liability for; the actuary of record stays accountable whichever tool produced the indication.

That accountability structure caps how much of the pricing and reserving workflow can move to a third-party engine, and it caps the venture case correspondingly. Workflow vendors sell speed to a buyer who can act on the metric this quarter. Pricing vendors sell to a buyer who cannot outsource the judgment the software claims to hold.

The incumbents behave accordingly. Guidewire's PricingCenter gets built on top of rather than replaced, and platforms absorb point solutions by acquisition, as Duck Creek did with SEND. Guidewire's own position in Sixfold is the clearest version: a stake in the decisioning layer adjacent to its rating engine, not inside it.

For a chief actuary the funding data argues for a split rather than a uniform answer. The workflow layer is now backed by companies with $50 million-plus in funding and multi-year runway, capitalization that removes the vendor-survival objection that governed procurement from 2022 through 2024. The rating and reserving core is where proprietary loss experience creates the moat, which is precisely why nobody is raising money to replicate it.

Buying the Workflow Layer Buys Its Failure Modes

The other side of that split is that underwriting throughput now rests on a small set of venture-funded companies. Gallagher Re's own data shows 82% of insurtechs that raised in Q1 will not be ready to raise again for at least six months, 17 percentage points longer than the broader venture market.

If a system embedded in the bind decision for $270 billion of premium hits a funding gap, that is an operational continuity exposure with no internal fallback, because avoiding the fallback build was the reason to buy.

Model concentration compounds it. Foundation model labs are selling directly to carriers alongside these vendors, so one upstream provider's outage, price change or model deprecation propagates through several nominally independent underwriting and claims systems at once. Patented governance controls and platforms like Norm AI exist because that concentration is accumulating faster than the frameworks meant to govern it.

The capital structure behind all of it points the same way. Every raise here funds software sitting alongside an insurance balance sheet rather than software bearing underwriting risk. Corgi is the partial exception, holding its own license, and even its proposition is speed-to-quote infrastructure rather than a pricing algorithm competing on loss ratio. A software vendor's revenue scales with carrier count and is insulated from cycle losses; a risk-bearing insurtech's revenue is exposed to exactly the volatility that ended several 2021-vintage full-stack companies.

So the question is not whether some vendor in this cohort fails. At an 82% re-raise delay, that is close to a base rate. It is which workflow functions can absorb an exit without breaking quote, bind or claims-payment continuity, and which have been bought precisely because nobody kept the capability to run them.

Further Reading

Sources